Hyderabad: The United States Global Commerce & Industry (USGCI) on Saturday launched its India chapter at the Global Business Summit here. The focus was on “Driving global growth through social investments and bilateral partnerships.”
Dr Mark Burns, adviser to US President Donald Trump, stated that the US’ vision was to double bilateral trade to $500 billion by 2030 through strategic investments, tariff reductions and deeper market access. He stressed that energy security was the main pillar of the partnership, saying the US was India’s leading supplier of liquified natural gas.
Dr Burns also outlined the broader vision for a bilateral trade agreement (BTA) to ease trade barriers. “A stronger India means a stronger America, and a stronger America means a stronger India. Together, through trade, technology, and trust, we build bridges of opportunity, raising innovation and prosperity for generations to come,” he added.
USGCI India chapter president and founder Dr Solomon said that the organisation was a bridge for businesses in the evolving global economy. He said fair trade, AI-driven market strategy and innovation were the main priorities. He requested Dr Burns to present USGCI’s mission to Trump.
Co-founder Ghazanfer Ali said that USGCI was an alternative to USAID’s grant-based model, giving scope for social investments and public-private partnerships to sustain global development projects. He announced plans to integrate AI and blockchain and USGCI’s global ambitions, with over 40 countries inviting it to establish national chapters.
Dr Srinivas Rao Pulijala, CEO of Apollo Medskills, pointed to India’s growing role in US healthcare with supplies of nearly 47 per cent of generic drugs. He spoke about AI’s role in diagnostics, medical research collaborations, and the potential for Indian healthcare professionals to develop as the next IT workforce.
A panel discussion featured entrepreneur Dr J.A. Chowdary and Deepak Khurana, vice-president, Procurement & SCM, Suven Pharmaceuticals. Khurana called called for easing US patent laws to allow faster entry of Indian generics, while other panelists viewed tariff hikes as opportunities for Indian industries like electric vehicles.
